In China, hepatocellular carcinoma (HCC) usually develops following a long history of chronic hepatitis B infection or cirrhosis. To evaluate the diagnostic role of annexin A2 (ANXA2), a possible tumor marker, in patients with hepatitis B virus (HBV)-related HCC, particularly those with a history of cirrhosis, the present study prospectively enrolled 87 patients with HBV-related HCC (with cirrh...

Among the common hemostatic issues of patients liver cirrhosis, deep venous thrombosis, pulmonary embolism, and intrahepatic thrombus development are more often ignored. With an estimated frequency ranging from 0.6 to 26 percent, portal thrombosis is another potentially dangerous consequence cirrhosis. Objectives: To determine various acquired thrombophilic / hypercoagulable states seen in with...

Cirrhosis is an increasing cause of morbidity and mortality in more developed countries, being the 14th most common cause of death worldwide but fourth in central Europe. Increasingly, cirrhosis has been seen to be not a single disease entity, but one that can be subclassified into distinct clinical prognostic stages, with 1-year mortality ranging from 1% to 57% depending on the stage. We revie...

Background Hepatitis B viral represents a pathology with a severe impact on public health. Worldwide, approximately 350 million individuals are chronically infected with hepatitis B virus (HBV). HBV is the leading cause of cirrhosis globally. Once chronic infection is established, approximately 30% of the patients will develop cirrhosis, and approximately one-quarter of patients with cirrhosis ...

Chronic hepatitis C infection is an important cause of cirrhosis and hepatocellular carcinoma (HCC). Antiviral therapy (AVT) for patients with cirrhosis due to hepatitis C may retard the progression of cirrhosis and prevent both the development of HCC as well as the recurrence of hepatitis C following liver transplantation. This review highlights the issues associated with AVT for patients with...

Patients with decompensated hepatic cirrhosis may present systemic alterations and dysfunction of multiple organs. Ascites, portal hypertension, esophageal varices, encephalopathy are common complications arising from cirrhosis. The aim this paper is to report a case patient liver the transjugular intrahepatic portosystemic shunt. Male, elderly, ex-alcoholic, diagnosed cirrhosis, ascites, varic...

Objective: The aim of this study was to determine the levels malondialdehyde (MDA) and antioxidants such as reduced glutathione (GSH), catalase (CAT), superoxide dismutase (SOD) in blood serum liver cirrhosis patients.Methods: İn This investigation, we took from 31 healthy individuals, 30 patients with Cirrhosis both males females. In study, MDA levels, SOD, GSH, CAT activities were measured sp...

conclusions in this patient, traditional medicine treatment improved the patient's general well-being, hematopoiesis and portal hypertension. furthermore, it improved his quality of life, although it had no effect on his liver function. we recommend more clinical trials on therapeutic effects of iranian traditional medicine on cryptogenic cirrhosis. introduction there are several disorders that...

Calcium absorption, as measured by whole-body retention of isotopic (47)calcium, was investigated in 10 controls and 10 patients with primary biliary cirrhosis before and after medium-chain triglyceride therapy. Absorption of calcium was impaired in eight patients with primary biliary cirrhosis, three of whom had normal serum bilirubin. Mean absorption was significantly less in patients with pr...